Ron Goldberg

Researchers investigated the association between asthma and helminthiasis in a cohort of children in Sri Lanka.

Researchers investigated whether point-of-care testing and antiviral treatment for influenza in homeless shelters was feasible and reduced influenza transmission.

Researchers investigated the relationship between use of oral anticoagulation therapy and clinical outcomes in patients hospitalized with COVID-19.

Investigators sought to characterize pediatric hospitalizations due to viral LRTIs unrelated to COVID-19 at a tertiary pediatric hospital in Barcelona, Spain.

What is the incidence of new-onset CVD, including ischemic heart disease, atrial fibrillation, and heart failure, in men and women of varying ages with COPD?

Are individuals with asthma more likely to experience respiratory symptoms after acute COVID-19 infection, and, if so, which symptoms are most prevalent?

Do individuals with asthma have a greater or lesser risk of severe and/or prolonged sequelae from COVID-19 — and does COVID-19 affect future asthma outcomes?

A meta-analysis examined the effect of undernutrition on treatment outcomes and sputum culture conversion in individuals with multidrug-resistant TB.

Investigators sought to evaluate the association between the development of atopic dermatitis (AD) and pre- and postnatal antibiotic exposure.

Researchers initiated a search of databases for studies of adolescents or children who had a mean age of 18 years and younger reporting a change of mental health measures from prepandemic to during the pandemic.

A systematic review and meta-analysis of nontuberculous mycobacterial pleuritis detailed patient characteristics, clinical presentations, and outcomes.

Researchers sought to assess outcomes among patients with hypercapnia following an acute hospital admission transitioning to home non-intensive ventilation.

Researchers sought to assess inpatient management and post-discharge sequelae in children with critical respiratory illness due to influenza.

A meta-analysis of 2000 to 2001 data estimated the disease burden of respiratory syncytial virus among adults at least 60 years of age in high-income countries.

A meta-analysis assessed use of fluvoxamine, a drug used to treat depression, for preventing hospitalization among those with COVID-19 infection.

Are changes in exercise habits among those with bronchiectasis associated with reduced cardiovascular disease risk — and how much exercise is optimal?

Is there an association between drug use and severe influenza-associated outcomes, including ICU admission, mechanical ventilation, and death?

Investigators sought to evaluate outcomes of SARS-CoV-2 vaccination and COVID-19 in adult patients treated with tralokinumab for atopic dermatitis (AD).

A clinical trial of individuals with post COVID-19 symptoms assessed the effects of a remote RMT rehabilitation program on HRQoL and exercise tolerance.

A study was conducted to compare cardiovascular function between patients who vape and patients who smoke combustible cigarettes.

How does split dosing of COVID-19 vaccines compare with conventional dosing with respect to antibody responsiveness and safety?

Can a commonly used white blood cell analysis be useful for COVID-19 screening?

What are the risk factors and optimal treatments for residual pulmonary radiological and functional abnormalities in patients who have had COVID-19-related ARDS?

A large, prospective study assessed the incidence and characteristics of long COVID symptoms experienced within families in adults, adolescents, and children.

Researchers sought to assess the relationship between parental factors and risk for hypertensive disorders in frozen embryo transfer pregnancy.

Is there a better, digital alternative to having patients with TB receive medications at a health care facility where they can be directly observed taking this medication?

Investigators developed and validated a machine learning tool providing an early indication of disease progression in community-acquired pneumonia.

In patients with COPD and asthma who are hospitalized for COVID-19, how does pre-hospitalization ICS use affect the clinical course of COVID-19?

A phase 3 clinical trial assessed whether vilobelimab added to standard care improved survival in patients with severe COVID-19 receiving invasive mechanical ventilation.

A study was conducted to determine the relationship between COVID-19 severity and risk for cardiovascular events 30 days following diagnosis.